Helixmith Co., Ltd Logo

Helixmith Co., Ltd

A biotechnology company specializing in the research and development of gene therapies.

084990 | KO

Overview

Corporate Details

ISIN(s):
KR7084990001
LEI:
Country:
South Korea
Address:
서울특별시 강서구 마곡중앙8로7길 21, 강서구

Description

Helixmith is a biotechnology company specializing in the research and development of gene therapies. Established in 1996, the company focuses on creating innovative biopharmaceuticals for diseases with significant unmet medical needs. Its core activities revolve around an extensive pipeline of next-generation gene therapy products. The primary therapeutic areas of focus include neurological and cardiovascular disorders, such as peripheral artery disease and coronary artery disease. Helixmith manages a comprehensive range of capabilities, from discovery and preclinical studies to clinical development of its drug candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2025-09-18 00:00
기업설명회(IR)개최
Korean 6.9 KB
2025-08-14 00:00
[기재정정]사업보고서 (2024.12)
Korean 1.9 MB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.3 MB
2025-07-09 00:00
임시주주총회결과
Korean 6.1 KB
2025-06-19 00:00
주주총회소집공고
Korean 51.3 KB
2025-06-18 00:00
[기재정정]주주총회소집결의
Korean 15.2 KB
2025-06-18 00:00
의결권대리행사권유참고서류
Korean 48.4 KB
2025-05-16 00:00
[기재정정]분기보고서 (2025.03)
Korean 1.1 MB
2025-05-15 00:00
주주총회소집결의
Korean 10.0 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.1 MB
2025-05-15 00:00
주주명부폐쇄기간또는기준일설정
Korean 5.7 KB
2025-05-02 00:00
소송등의판결ㆍ결정 (주주총회소집허가)
Korean 6.2 KB
2025-03-27 00:00
정기주주총회결과
Korean 22.0 KB
2025-03-27 00:00
[기재정정]사업보고서 (2024.12)
Korean 1.9 MB

Automate Your Workflow. Get a real-time feed of all Helixmith Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Helixmith Co., Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Helixmith Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.